NasdaqGS - Nasdaq Real Time Price
USD
Canopy Growth Corporation (CGC)
1.0900
-0.0300
(-2.68%)
At close: May 29 at 4:00:00 PM EDT
1.0900
0.0000
(0.00%)
After hours: May 29 at 7:53:17 PM EDT
Trade CGC on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for CGC
- Previous Close
1.1200 - Open
1.1217 - Bid 0.9374 x 100
- Ask 1.2500 x 100
- Day's Range
1.0700 - 1.1250 - 52 Week Range
0.8440 - 2.3800 - Volume
7,701,404 - Avg. Volume
10,007,044 - Market Cap (intraday)
489.498M - Beta (5Y Monthly) 2.39
- PE Ratio (TTM)
-- - EPS (TTM)
-1.3400 - Earnings Date Jun 15, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.78
Recent News
View More
Performance Overview
Trailing total returns as of 5/29/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
CGC
6.03%
S&P/TSX Composite index (^GSPTSE)
9.11%
1-Year Return
CGC
36.26%
S&P/TSX Composite index (^GSPTSE)
32.65%
3-Year Return
CGC
87.57%
S&P/TSX Composite index (^GSPTSE)
74.12%
5-Year Return
CGC
99.58%
S&P/TSX Composite index (^GSPTSE)
75.14%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 5/29/2026
-
Market Cap
460.12M
-
Enterprise Value
375.82M
-
Trailing P/E
--
-
Forward P/E
20.37
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
1.30
-
Price/Book (mrq)
0.84
-
Enterprise Value/Revenue
1.86
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-117.31%
-
Return on Assets (ttm)
-2.64%
-
Return on Equity (ttm)
-48.50%
-
Revenue (ttm)
278.39M
-
Net Income Avi to Common (ttm)
-327.29M
-
Diluted EPS (ttm)
-1.3400
Balance Sheet and Cash Flow
-
Total Cash (mrq)
371.48M
-
Total Debt/Equity (mrq)
33.65%
-
Levered Free Cash Flow (ttm)
-25.98M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
1.0900
-2.68%
Mkt Cap
489.498M
Industry
Drug Manufacturers—Specialty & Generic
5.51
-2.48%
Mkt Cap
659.019M
Industry
Drug Manufacturers—Specialty & Generic
3.6000
-1.91%
Mkt Cap
212.856M
Industry
Drug Manufacturers—Specialty & Generic
3.5050
-1.54%
Mkt Cap
2.778B
Industry
Drug Manufacturers—Specialty & Generic
4.9600
-1.98%
Mkt Cap
CAD
293.268M
Industry
Drug Manufacturers—Specialty & Generic
9.29
-3.99%
Mkt Cap
1.786B
Industry
Drug Manufacturers—Specialty & Generic
7.58
-2.45%
Mkt Cap
CAD
906.6M
Industry
Drug Manufacturers—Specialty & Generic
1.1400
0.00%
Mkt Cap
160.484M
Industry
Drug Manufacturers—Specialty & Generic
8.07
+0.75%
Mkt Cap
1.767B
Industry
Drug Manufacturers—Specialty & Generic
12.78
-4.48%
Mkt Cap
CAD
2.458B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Canopy Growth: Dropping Coverage
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
RatingPrice Target -
Canopy Growth: Dropping Coverage
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
RatingPrice Target -
Canopy Growth: Board Member Luc Mongeau to Serve as New CEO Starting in January
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
RatingPrice Target -
Canopy Growth Earnings: Value Destruction Likely as Equity Will Be Used to Fund Ongoing Cash Burn
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
RatingPrice Target
